Mbrf Global Foods Company S.a. · BMFBOVESPA:MBRF3
Mbrf Global Foods — Marfrig Global Foods — Q4 2017 Earnings Presentation
12 slides from Mbrf Global Foods's earnings presentation, Mar 28, 2018
Slide 1: Earnings Conference Call 4Q17 & 2017
Earnings Conference Call 4Q17 & 2017 28 March 2018
Slide 2: Disclaimer
Disclaimer This material is a presentation of general information about Marfrig Global This presentation includes forward-looking statements. Such statements do Foods S.A. and its consolidated subsidiaries (jointly the “Corporation”) on not constitute historical fact and reflect the beliefs and expe
Slide 3: Highlights 4Q17
M a r f r i g G l o b a l F o o d s Highlights 4Q17 Increase of 24% in Adj. EBITDA compared to 4Q16 Margin of 9.3%, high range of long-term target about 8.5% - 9.5% (consolidated) Ramp Up and achievement of 300,000 head of cattle slaughtered in December (Brazil) Growth of 34% in export volumes of fr
Slide 4: Beef Division Result
NET REVENUE EBITDA AJUSTED AND MARGIN (R$ million) (R$ million and %) 18% 4.000 37% 3.400 3,006 8.7% 2,556 350 7.5% B E E F D I V I S I O N 2.800 9,00% 1,426 Result 300 Resultado 7,00% 1,102 2.200 1.600 250 5,00% 200 3,00% 1,580 1.000 1,454 150 262 1,00% 400 -200 44TQ1 17 7 100 192 -1,00% 4Q16 4Q17
Slide 5: Keystone Division Result
NET REVENUE EBITDA AJUSTED AND MARGIN (US$ million) (US$ million and %) -1% 720 -4% 700 680 K E Y S TO N E D I V I S I O N 9.6% Result 660 87 9.4% 9,70% 9,50% 640 712 705 9,30% 57 9,10% 620 8,90% 4Q17 27 69 66 8,70% 600 8,50% 8,30% 580 -3 8,10% 4Q16 4Q17 4Q16 4Q17 TOTA L V O L U M E Volume reduction
Slide 6: Consolidated Performance
NET REVENUE EBITDA AJUSTED AND MARGIN R$ (million) (R$ million and %) 8% 24% 5200 900 9.3% 4700 C o n s o l i d a t e d 10,00% 800 8.1% perfomance 9,00% 4200 5,298 700 4,899 600 8,00% 3700 500 7,00% 400 6,00% 3200 300 4Q17 493 5,00% 4Q16 4Q17 200 398 4,00% 100 0 3,00% -100 4Q16 4Q17 2,00% TOTA L V O
Slide 7: Leverage & Debt
leverage & debt Leverage and Adjusted EBITDA 4Q17 Goal 4.36x 4.55x 3.94x 2.5x by 2018 LTM Adj. EBITDA 1,972 1,613 1,708 * Normalized ** Normalized Adj. EBITDA and annualized 3Q17 4Q17* 4Q17** US$ million Short Term Gross Debt Cash & Equiv. 15% 3% Medium Cost -7% (% a.a.) 6.38% a 3,650 3,757 Average
Slide 8: Cash Flow
Cash flow consolidated4 Q 1 7 R$ million OCF 88 (247) Capex (350) (192) Interest FCL Improvement of (236) (599) (12) Operational Flow, and Interest PERT lower consumption of expenditure FCL Total working capital stability discontinued FCF Adhesion to the Special Maintaining the Tax Regularization hi
Slide 9: Net Result Consolidated
Net Result Consolidated 4Q17 NET LOSS CONTINUED (R$ million) 4Q16 4Q17 50 0 -50 (8) -100 (230) -150 -200 -250 -300 In 4Q17 net income from continuing operations recorded a loss of approximately R$ 8 million, the lowest since 2015 9
Slide 10: Marfrig Result
NET REVENUE EBITDA AJUSTED AND MARGIN (R$ million) (R$ millions and %) 19450 -1% 18950 6% 18450 17950 8.6% 9.2% 2859 10,00% 9,00% 17450 2359 8,00% 7,00% 1859 16950 18,828 6,00% 18,578 1359 5,00% 16450 859 1,614 1,708 4,00% 3,00% Result 15950 359 2,00% 15450 M A R F R I G 2016 2017 14950 2017 2016 20
Slide 11: Final Considerations
Final Considerations Perspectiva 2 0 1 8 S C E N A R I O Outlook for the protein sector remains favorable Positive Free Cash Flow expected Capital restructuring through equity sale at Keystone Achieving leverage ratio of 2.5x Investments returning to historical levels 11
Slide 12: Earnings Conference Call
Earnings Conference Call 4Q17 & 2017 Investor relations www.ir.marfrig.com.br